1. Agaimy, A., Witkowski, L., Stoehr, R., Cuenca, J., González-Muller, C. A., Brütting, A., Bährle, M., Mantsopoulos, K., Amin, R., Hartmann, A., Metzler, M., Amr, S. S., Foulkes, W. D., Sobrinho-Simões, M., & Eloy, C. (2020). Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term “thyroblastoma” more appropriate?. Virchows Archiv: An International Journal of Pathology, 477(6), 787–798. https://doi.org/10.1007/s00428-020-02853-1.
2. Balajee, A. S., Machwe, A., May, A., Gray, M. D., Oshima, J., Martin, G. M., … Bohr, V. A. (1999). The Werner syndrome protein is involved in RNA polymerase II transcription. Molecular Biology of the Cell, 10(8), 2655–2668. https://doi.org/10.1091/mbc.10.8.2655.
3. Bashir, E. A., Ahmed, S., Murtaza, B., Abbasi, M. H., Shah, S. S., Tamimy, M. S., & Awan, A. S. (2004). Follicular carcinoma thyroid in Pendred syndrome. Journal of the College of Physicians and Surgeons–Pakistan, 14(11), 679–680. https://doi.org/11.2004/jcpsp.679680.
4. Beuschlein, F., Fassnacht, M., Assie, G., Calebiro, D., Stratakis, C. A., Osswald, A., … Allolio, B. (2014). Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. The New England Journal of Medicine, 370(11), 1019–1028. https://doi.org/10.1056/NEJMoa1310359.
5. Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., … et al. (1994). Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Research, 54(5), 1298–1304.